On April 23, 2026, the HHS Office of Inspector General (OIG) quietly—but pointedly—added two new FAQs to its “General Questions Regarding Certain Fraud and Abuse Authorities.” Although the principles articulated are not new, the timing and clarity of these FAQs reflect OIG’s continued effort to correct common—and risky—misunderstandings in the health care industry regarding the
Office of Inspector General (OIG)
DOJ Enforcement of Clinical Laboratories: Trends from Q4 2025
By Danielle Tangorre & Guest Contributor on
Posted in The ColLABorative Brief
This post was co-authored by Paul Palma, legal intern at Robinson+Cole. Paul is not admitted to practice law.
The final quarter of 2025 saw continued enforcement actions against clinical labs and other related healthcare entities. The Office of Inspector General (OIG) and Department of Justice (DOJ) heavily focused on False Claims Act (FCA) violations, Anti-Kickback…